FcγRIV:: A novel FcR with distinct IgG subclass specificity

被引:540
作者
Nimmerjahn, F [1 ]
Bruhns, P [1 ]
Horiuchi, K [1 ]
Ravetch, JV [1 ]
机构
[1] Rockefeller Univ, Lab Mol Genet & Immunol, New York, NY 10021 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1016/j.immuni.2005.05.010
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Mouse IgG subclasses display a hierarchy of in vivo activities, with IgG2a and IgG2b showing the greatest protective and pathogenic properties. These enhanced activities result, in part, from their ability to bind to a novel, 7 chain-dependent, activating IgG Fc receptor, Fc gamma RIV. Fc gamma RIV maps in the 75 kb genomic interval between Fc gamma RII and Fc gamma RIII; its expression is restricted to myeloid lineage cells, and it binds to IgG2a and IgG2b with intermediate affinity. No binding to IgG1 or IgG3 was observed. Blocking Fc gamma RIV binding to pathogenic anti-platelet antibodies is sufficient to protect mice from antibody-induced thrombocytopenia. Thus, the Fc gamma R system has evolved distinct activation receptors displaying selectivity for IgG subclasses, with IgG1 antibodies exclusively dependent on Fc gamma RIII, whereas IgG2a and IgG2b show preferential dependence on Fc gamma RIV activation. These distinct binding affinities for the IgG subclasses to Fc gamma Rs account for their differential protective and pathogenic activities in vivo.
引用
收藏
页码:41 / 51
页数:11
相关论文
共 53 条
[31]   Expression of a functional high-affinity IgG receptor, FcγRI, on human mast cells:: Up-regulation by IFN-γ [J].
Okayama, Y ;
Kirshenbaum, AS ;
Metcalfe, DD .
JOURNAL OF IMMUNOLOGY, 2000, 164 (08) :4332-4339
[32]   Differential modulation of stimulatory and inhibitory Fcγ receptors on human monocytes by Th1 and Th2 cytokines [J].
Pricop, L ;
Redecha, P ;
Teillaud, JL ;
Frey, J ;
Fridman, WH ;
Sautès-Fridman, C ;
Salmon, JE .
JOURNAL OF IMMUNOLOGY, 2001, 166 (01) :531-537
[33]   Kinetics of cellular responses to intraperitoneal Brugia pahangi infections in normal and immunodeficient mice [J].
Ramalingam, T ;
Rajan, B ;
Lee, J ;
Rajan, TV .
INFECTION AND IMMUNITY, 2003, 71 (08) :4361-4367
[34]   FC-RECEPTORS [J].
RAVETCH, JV ;
KINET, JP .
ANNUAL REVIEW OF IMMUNOLOGY, 1991, 9 :457-492
[35]   Divergent roles for Fc receptors and complement in vivo [J].
Ravetch, JV ;
Clynes, RA .
ANNUAL REVIEW OF IMMUNOLOGY, 1998, 16 :421-432
[36]  
RAVETCH JV, 2003, FUNDAMENTAL IMMUNOLO, P685
[37]   Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor [J].
Samuelsson, A ;
Towers, TL ;
Ravetch, JV .
SCIENCE, 2001, 291 (5503) :484-486
[38]   OPSONIZATION OF CRYPTOCOCCUS-NEOFORMANS BY A FAMILY OF ISOTYPE-SWITCH VARIANT ANTIBODIES SPECIFIC FOR THE CAPSULAR POLYSACCHARIDE [J].
SCHLAGETER, AM ;
KOZEL, TR .
INFECTION AND IMMUNITY, 1990, 58 (06) :1914-1918
[39]  
SHER A, 1992, ANNU REV IMMUNOL, V10, P385, DOI 10.1146/annurev.iy.10.040192.002125
[40]   Characterization and crystallization of soluble human fcγ receptor II (CD32) isoforms produced in insect cells [J].
Sondermann, P ;
Jacob, U ;
Kutscher, C ;
Frey, J .
BIOCHEMISTRY, 1999, 38 (26) :8469-8477